Inhibition of CRM1 activity sensitizes endometrial and ovarian cell lines to TRAIL-induced cell death. [electronic resource]
Producer: 20190513Description: 39 p. digitalISSN:- 1478-811X
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Cisplatin -- pharmacology
- Drug Synergism
- Endometrial Neoplasms -- pathology
- Fatty Acids, Unsaturated -- pharmacology
- Female
- Humans
- Karyopherins -- antagonists & inhibitors
- Ovarian Neoplasms -- pathology
- Receptors, Cytoplasmic and Nuclear -- antagonists & inhibitors
- TNF-Related Apoptosis-Inducing Ligand -- pharmacology
- Tumor Suppressor Protein p53 -- metabolism
- Exportin 1 Protein
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.